4 years ago

The effect of plasma auto-IgGs on CD4(+) T cell apoptosis and recovery in HIV-infected patients under antiretroviral therapy.

Zhiqiang Qin, Lisa Martin, Tongwen Ou, Sonya Heath, Zhen Li, Elizabeth Ogunrinde, Hao Wu, Tao Zhang, Guoyang Liao, Zhenwu Luo, Lei Huang, Lei Ma, Zhuang Wan, Wei Jiang, Zejun Zhou, Jiafeng Zhang
Although effective antiretroviral therapy (ART) suppresses HIV viral replication, prevents AIDS-related complications, and prolongs life, a proportion of patients fails to restore the patients' CD4(+) T cell number to the level of healthy individuals. Increased mortality and morbidity have been observed in these patients. In the current study, we have investigated the role of auto-IgGs in CD4(+) T cell apoptosis and recovery in a cross-sectional study. All HIV(+) subjects were on viral-suppressive ART treatment with a different degree of CD4(+) T cell reconstitution. Total auto-IgG binding on CD4(+) T cell surfaces and its associated apoptosis and CD4(+) T cell recovery were analyzed by flow cytometry ex vivo. Total IgGs from plasma were tested for their binding capacities to CD4(+) T cell surfaces and their mediation to CD4(+) T cell death through NK cell cytotoxicity in vitro. HIV(+) subjects had increased surface binding of auto-IgGs on CD4(+) T cells compared with healthy controls, and IgG binding was associated with elevated CD4(+) T cell apoptosis in HIV(+) subjects but not in healthy controls. Plasma IgGs from HIV(+) subjects bound to CD4(+) T cells and induced cell apoptosis through NK cytotoxicity in vitro. Soluble CD4 (sCD4) preincubation prevented NK cell-mediated CD4(+) T cell death. Our results suggest that plasma autoantibodies may play a role in some HIV(+) patients with poor CD4(+) T cell recovery under viral-suppressive ART.

Publisher URL: http://doi.org/10.1189/jlb.5A0617-219R

DOI: 10.1189/jlb.5A0617-219R

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.